Stay updated on MK-1308A-008 Clinical Trial: MK-1308A vs Other Treatments

Sign up to get notified when there's something new on the MK-1308A-008 Clinical Trial: MK-1308A vs Other Treatments page.
Latest website image capture
Clouds background image

Latest updates to the MK-1308A-008 Clinical Trial: MK-1308A vs Other Treatments page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The change on the webpage possibly concerns Medical and healthcare-related publications and documentation. The value 'Participation Criteria Collaborators No information provided' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change reflects a more detailed description of the criteria researchers are looking for in potential participants.
    Difference
    21%
    Check dated 2024-05-22T08:08:35.000Z thumbnail image
  5. Check
    5 days ago
    Change Detected
    Summary
    The value 10 has been updated to 17 on the webpage, indicating a change in the medical oncology department locations in Madrid, Asturias, Cantabria, and Cataluna. This change possibly reflects updates in healthcare facilities and services provided in these regions.
    Difference
    2%
    Check dated 2024-05-21T07:46:02.000Z thumbnail image
  6. Check
    12 days ago
    Change Detected
    Summary
    The value of the Primary Completion Date has recently changed from 'Estimated' to '2025-10-20'. This change indicates a more specific expected completion date for the study on the evaluation of co-formulated pembrolizumab/quavonlimab versus other treatments in participants with MSI-H or dMMR Metastatic Stage IV Colorectal Cancer.
    Difference
    0.0%
    Check dated 2024-05-14T01:57:48.000Z thumbnail image
  7. Check
    15 days ago
    Change Detected
    Summary
    The value 04 11 04 10 04 11 04 on the webpage has been updated to 05 10 Baranya Locations Pécs, Baranya, Hungary, 7624 Recruiting Pécsi Tudományegyetem Klinikai Központ-Onkoterápiás Intézet ( Site 2009) Contact : Study Coordinator 36304400442 05 09 (Estimated) 05 10 05. This change likely pertains to updates in the recruitment status and contact information for a medical study related to evaluating the efficacy and safety of co-formulated pembrolizumab/quavonlimab versus other treatments in participants with MSI-H or dMMR Metastatic Stage IV Colorectal Cancer.
    Difference
    0.9%
    Check dated 2024-05-11T17:57:04.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-04-30T22:35:01.000Z thumbnail image

Stay in the know with updates to MK-1308A-008 Clinical Trial: MK-1308A vs Other Treatments

Enter your email address, and we'll notify you when there's something new on the MK-1308A-008 Clinical Trial: MK-1308A vs Other Treatments page.